Market Share of Global Antisense and RNAi Therapeutics Industry
The antisense and RNAi therapeutics market is consolidated in nature due to the presence of a limited number of companies operating across the globe. The competitive landscape includes an analysis of a few international as well as local companies that operate in the market such as Alnylam Pharmaceuticals, Inc., Biogen Inc., Ionis Pharmaceuticals (Akcea Therapeutics, Inc.), Sarepta Therapeutics, Inc., Novartis AG, Silence Therapeutics, Arbutus Biopharma (Formerly Called Tekmira Pharmaceuticals), Isarna Therapeutics GmbH, Gene Signal International SA, Arrowhead Pharmaceuticals, Inc., and Benitec Biopharma Ltd, among others.
Antisense & RNAi Therapeutics Market Leaders
Alnylam Pharmaceuticals, Inc.
Biogen Inc.
Ionis Pharmaceuticals (Akcea Therapeutics, Inc.)
Sarepta Therapeutics, Inc.
Novartis AG
*Disclaimer: Major Players sorted in no particular order
